-
News
OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease
OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease…
Read More » -
News
CleverTap Names Pravin Laghaate as Vice President, Europe, and UK
[ad_1] Mountain View, Calif., London, UK, Amsterdam, Netherlands, & Mumbai, India – (NewMediaWire) – April 27, 2023 – (ACN Newswire)…
Read More » -
News
Ohanae Announces New Deposit Coin for Capital Markets
[ad_1] NEW YORK, NY – (NewMediaWire) – April 26, 2023 – Ohanae, Inc. (“Ohanae”), New York’s leading Web3 equity crowdfunding platform,…
Read More » -
News
International Government Leaders Talk Crypto & Digital Assets in Washington
[ad_1] Washington, D.C. – (NewMediaWire) – April 26, 2023 – (ACN Newswire) – The Government Blockchain Association (GBA) is set to host…
Read More » -
U.S. adults who felt discrimination at work faced increased risk of high blood pressure
[ad_1] Research Highlights: U.S. adults who reported feeling highly discriminated against at work had an increased risk of developing high…
Read More »